Inovio Pharma (INO) - Hot FDA News

Inovio Pharma (INO) – Hot FDA News

Oct 27, 2022 04:34 PM Inovio Pharma (INO) has discontinued its internally funded efforts to develop INO-4800 as a COVID-19 heterologous booster vaccine
Nov 9, 2021 08:13 AM U.S. FDA lifts clinical hold on Inovio's COVID-19 vaccine trial
Nov 9, 2021 08:03 AM
May 12, 2021 08:00 AM
May 10, 2021 08:02 AM
Apr 15, 2021 08:07 AM
Sep 28, 2020 07:03 AM
Jul 30, 2020 08:05 AM
Jun 30, 2020 07:37 AM
May 20, 2020 07:03 AM
Apr 28, 2020 08:03 AM
Apr 6, 2020 08:32 AM
Mar 3, 2020 08:03 AM
Jan 30, 2020 06:14 AM
Jun 15, 2017 08:05 AM
Jun 8, 2017 06:03 AM
May 24, 2017 02:31 PM
Oct 24, 2016 08:01 AM
Feb 17, 2016 07:16 AM